DANSK BIOTEK organizes four major plenary meetings for our members throughout the year to increase our members' knowledge regarding specific biotech topics and to facilitate networking. The events usually take place in February, May, September and November.

We also organize approximately six "saloon" meetings annually. They are small, intimate, "meet the expert" meetings with typically 6-20 participants advocating more in-depth discussion and knowledge-sharing on specific themes.

14 Aug 2014

Det amerikanske Defense Threat Reduction Agency vil støtte præklinisk udvikling af Evolva lægemiddel

Evolva has entered into a contract (HDTRA1-14-C-0122) with the US Defense Threat Reduction Agency (DTRA) for the program “GC-072: The First Oral Antibiotic for the Treatment of Acute Melioidosis and Select Agents”. DTRA will fund USD 6.5 million for the first 15-month stage and up to an additional USD 8.6 million if the two remaining stages (2 years) are executed.

Evolva continues to pursue options to partner its pharmaceutical pipeline in line with its strategy of focusing on high value ingredients for health, wellness and nutrition.

If you can't find it here or have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2014 Danskbiotek. All rights reserved.